BioCryst Pharmaceuticals Inc - Company & Market Research Reports

BioCryst Pharmaceuticals is a biotechnology company that designs and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. BioCryst's core development programs include BCX7353 and additional 2nd generation oral inhibitors of plasma kallikrein for hereditary angioedema; and BCX4430 (GALIDESIVIR), a broad spectrum antiviral for hemorrhagic fevers. The company was founded in 1986 and is headquartered in Durham, North Carolina.

From
From
From
From
From
From
From
From
From
From
From
Yellow Fever - Pipeline Review, H2 2018 - Product Thumbnail Image

Yellow Fever - Pipeline Review, H2 2018

  • Drug Pipelines
  • 52 Pages
From
Yellow Fever - Pipeline Review, H1 2018 - Product Thumbnail Image

Yellow Fever - Pipeline Review, H1 2018

  • Drug Pipelines
  • 49 Pages
From
From
From
Loading Indicator
adroll